Pyrogen Testing Market by Produc, by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019

Pyrogen testing is used to determine the presence of bacterial toxins in pharmaceutical, biotechnology, and medical device products, intended for medical or veterinary use. Spot checks of all batches of pharmaceutical, biotechnology, and medical device products are mandatory for regulatory approval and market release. Pyrogen testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the pyrogen testing market. The global pharmaceutical industry is expected to grow at a CAGR between 5% and 8%. According to the IMS Institute of Healthcare Informatics, the global biologics market has increased from $46 billion in 2002 to $169 billion in 2012. Biologics accounted for a share of 11% of the total sales of drugs in 2002, which increased to 18% in 2012. It is estimated that this figure will rise to 20% by 2017, with a total market value of $221 billion.

This report segments the pyrogen testing market on the basis of applications, products, tests, and geographies. The application segments included in this report are pharmaceuticals and biologicals, medical devices, and other applications. The product segments of this market are instruments, kits & reagents, and services. The test segments included in this report are in vitro test, LAL test, and rabbit pyrogen test. The report includes geographic analysis of the pyrogen testing market in 19 geographic and regional segments. The geographic segments included in this report are Asia, Europe, North America and the Rest of the World (RoW). The regional segments of Asia are China, India, Japan, and the Rest of Asia. The regional segments of Europe are France, Germany, Italy, Spain, the U.K., and the Rest of Europe. The regionals segments of North America are Canada and the U.S. The regional segments of RoW are Africa, Pacific and Oceania, and South America, Central America, & the Caribbean.

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global pyrogen testing market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their pyrogen testing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the pyrogen testing market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
‧ Product Development/Innovation: Product portfolios of top players in the pyrogen testing market.
‧ Competitive Assessment: Analysis of market shares, strategies, geographic and business segments, and product portfolios of leading players in the pyrogen testing market
‧ Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various pyrogen testing products across geographies
‧ Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the pyrogen testing market

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 MARKET SIZE ESTIMATION 21
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3 MARKET SHARE ESTIMATION 25
2.3.1 KEY DATA FROM SECONDARY SOURCES 25
2.3.2 KEY DATA FROM PRIMARY SOURCES 25
2.4 ASSUMPTIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 32
4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL PYROGEN TESTING MARKET 32
4.2 LIFE CYCLE ANALYSIS, BY REGION 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.2.1 BY APPLICATION 37
5.2.2 BY PRODUCT 37
5.2.3 BY TEST 38
5.3 MARKET DYNAMICS 39
5.3.1 DRIVERS 40
5.3.1.1 Rapid growth in pharmaceutical and biotechnology industries 40
5.3.1.2 Increasing number of new drug launches 40
5.3.1.3 Strong trend of R&D investments in life sciences research 41
5.3.1.4 Increasing government support for pharmaceutical and biotechnology industries 41
5.3.2 RESTRAINTS 43
5.3.2.1 High degree of consolidation acts as an entry barrier for new entrants 43
5.3.3 OPPORTUNITIES 43
5.3.3.1 Increasing pharmaceutical outsourcing 43
5.3.3.2 Developing countries present significant opportunities for the pyrogen testing market 44
5.3.4 TRENDS 44
5.3.4.1 Shift from animal-based testing to in vitro testing 44
6 INDUSTRY TRENDS 46
6.1 INTRODUCTION 46
6.2 PORTER’S FIVE FORCES ANALYSIS 46
6.2.1 THREAT OF NEW ENTRANTS 47
6.2.2 THREAT OF SUBSTITUTES 47
6.2.3 BARGAINING POWER OF BUYERS 47
6.2.4 BARGAINING POWER OF SUPPLIERS 47
6.2.5 INTENSITY OF RIVALRY 47
6.3 STRATEGIC BENCHMARKING 48
6.3.1 EXPANSIONS 48
6.4 SUPPLY CHAIN ANALYSIS 49
6.4.1 KEY INFLUENCERS 50
7 PYROGEN TESTING MARKET, BY PRODUCT 51
7.1 INTRODUCTION 52
7.2 KITS AND REAGENTS 53
7.3 SERVICES 55
7.4 INSTRUMENTS 56
8 PYROGEN TESTING MARKET, BY APPLICATION 58
8.1 INTRODUCTION 59
8.2 PHARMACEUTICALS AND BIOLOGICS 60
8.3 MEDICAL DEVICES 62
8.4 OTHER APPLICATIONS 63
9 PYROGEN TESTING MARKET, BY TEST 65
9.1 INTRODUCTION 66
9.2 LAL TESTS 67
9.3 IN VITRO PYROGEN TESTS 70
9.4 RABBIT TESTS 73
10 PYROGEN TESTING MARKET, BY REGION 77
10.1 INTRODUCTION 78
10.2 NORTH AMERICA 80
10.2.1 U.S. 85
10.2.2 CANADA 87
10.3 EUROPE 89
10.3.1 GERMANY 94
10.3.2 U.K. 96
10.3.3 FRANCE 99
10.3.4 ITALY 101
10.3.5 SPAIN 103
10.3.6 REST OF EUROPE (ROE) 106
10.4 ASIA 108
10.4.1 CHINA 113
10.4.2 JAPAN 115
10.4.3 INDIA 118
10.4.4 REST OF ASIA (ROA) 120
10.5 REST OF THE WORLD (ROW) 123
10.5.1 SOUTH AMERICA, CENTRAL AMERICA, & THE CARIBBEAN 126
10.5.2 PACIFIC AND OCEANIA 129
10.5.3 AFRICA 131
11 COMPETITIVE LANDSCAPE 134
11.1 OVERVIEW 134
11.2 MARKET SHARE ANALYSIS 135
11.3 COMPETITIVE SITUATION AND TRENDS 137
11.3.1 EXPANSIONS 137
11.3.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 139
11.3.3 NEW PRODUCT LAUNCHES 140
11.3.4 ACQUISITIONS 141
11.3.5 OTHER DEVELOPMENTS 142
12 COMPANY PROFILES 143
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 INTRODUCTION 143
12.2 ASSOCIATES OF CAPE COD, INC. 144
12.3 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 146
12.4 LONZA GROUP 149
12.5 MERCK & CO., INC. 152
12.6 WAKO CHEMICALS USA, INC. 154
12.7 ELLAB A/S 155
12.8 GENSCRIPT 156
12.9 HYGLOS GMBH 157
12.10 SIGMA-ALDRICH CORPORATION 159
12.11 THERMO FISHER SCIENTIFIC, INC. 161
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
13 APPENDIX 163
13.1 INSIGHTS OF INDUSTRY EXPERTS 163
13.2 DISCUSSION GUIDE 164
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 166
13.4 AVAILABLE CUSTOMIZATIONS 168
13.5 RELATED REPORTS 169